Company Filing History:
Years Active: 2006-2012
Title: Innovations of Melody Jensen in Neurotoxin Research
Introduction
Melody Jensen is a prominent inventor based in Frederick, MD (US). She has made significant contributions to the field of neurotoxin research, particularly in the development of recombinant light chains of botulinum neurotoxins. Her work has implications for both research and clinical therapy.
Latest Patents
Melody Jensen holds 2 patents. Her latest patents focus on the construction, expression, and purification of synthetic or recombinant light chain botulinum neurotoxin genes from all botulinum neurotoxin serotypes. The methods described in her patents can yield 1.1 grams of the light chain per liter of culture. The light chain product is noted for its stability and proteolytic activity. Jensen's research highlights the potential of these neurotoxins, which are known to induce lethal neuromuscular paralysis by inhibiting exocytosis at the neuromuscular junction.
Career Highlights
Melody Jensen is affiliated with the US Government as represented by the Secretary of the Army. Her innovative work in neurotoxin research has positioned her as a key figure in the scientific community. She has successfully constructed and overexpressed synthetic genes for the light chain of neurotoxin serotype A, demonstrating her expertise in this specialized field.
Collaborations
Melody Jensen collaborates with Leonard A. Smith, further enhancing her research capabilities and contributions to the field of neurotoxin studies.
Conclusion
Melody Jensen's work in the development of recombinant light chains of botulinum neurotoxins showcases her innovative spirit and dedication to advancing scientific knowledge. Her contributions are vital for both research and therapeutic applications in neurotoxin research.